Plain-English translation of NCT06547684 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing extracorporeal shock wave therapy (ESWT) — a non-invasive treatment that uses acoustic pulses to reduce muscle stiffness — in stroke patients who experience a condition called spastic equinus foot, where the foot becomes permanently pointed downward. Researchers want to see whether one treatment session works as well as three sessions given over three weeks, and how long the benefits last.
After a stroke, many patients develop painful muscle stiffness in the leg and foot that makes walking difficult and limits independence. This treatment has shown promise in smaller studies, but doctors need to know the best way to use it — whether one session is enough or if multiple sessions work better.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either one shock wave therapy session or three sessions (one per week for three weeks). Each session targets the calf muscles using ultrasound guidance to ensure accuracy. You'll have follow-up visits at weeks 1, 4, 8, 12, 20, 24, 36, and 48 to measure how your foot stiffness improves, how far you can walk, your balance, and your quality of life.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Spain
Sponsor
Teresa Mateu Campos
Enrollment target
~60 participants
Started
August 2020
Primary completion
September 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Teresa Mª Mateu Campos
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.